日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain

在西班牙的真实世界环境中,利用基于杂交捕获的下一代测序技术对实体瘤进行可操作的突变谱分析。

Zazo, Sandra; Pérez-Buira, Sandra; Carvajal, Nerea; Plaza-Sánchez, Jenifer; Manso, Rebeca; Pérez-González, Nuria; Dominguez, Carolina; Prieto-Potin, Iván; Rubio, Jaime; Dómine, Manuel; Lozano, Virginia; Mohedano, Patricia; Carcedo, David; Carias, Rafael; Rojo, Federico

Exercise and tumor proteome: insights from a neuroblastoma model

运动与肿瘤蛋白质组:来自神经母细胞瘤模型的启示

Plaza-Florido, Abel; Gálvez, Beatriz G; López, Juan A; Santos-Lozano, Alejandro; Zazo, Sandra; Rincón-Castanedo, Cecilia; Martín-Ruiz, Asunción; Lumbreras, Jorge; Terron-Camero, Laura C; López-Soto, Alejandro; Andrés-León, Eduardo; González-Murillo, África; Rojo, Federico; Ramírez, Manuel; Lucia, Alejandro; Fiuza-Luces, Carmen

miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies

miR-99a-5p通过COX-2/ABCG2轴调控三阴性乳腺癌的阿霉素耐药性:从发现到体内研究

Garrido-Cano, Iris; Adam-Artigues, Anna; Lameirinhas, Ana; Blandez, Juan F; Candela-Noguera, Vicente; Rojo, Federico; Zazo, Sandra; Madoz-Gúrpide, Juan; Lluch, Ana; Bermejo, Begoña; Sancenón, Felix; Cejalvo, Juan Miguel; Martínez-Máñez, Ramón; Eroles, Pilar

Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer

HER2阳性乳腺癌中的肿瘤浸润淋巴细胞和免疫反应

Luque, Melani; Sanz-Álvarez, Marta; Morales-Gallego, Miriam; Madoz-Gúrpide, Juan; Zazo, Sandra; Domínguez, Carolina; Cazorla, Alicia; Izarzugaza, Yann; Arranz, Juan Luis; Cristóbal, Ion; Rojo, Federico

The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models.

新型口服 mTORC1/2 抑制剂 TAK-228 可逆转 HER2 阳性乳腺癌模型中的曲妥珠单抗耐药性

Sanz-Álvarez Marta, Martín-Aparicio Ester, Luque Melani, Zazo Sandra, Martínez-Useros Javier, Eroles Pilar, Rovira Ana, Albanell Joan, Madoz-Gúrpide Juan, Rojo Federico

In search of an evidence-based strategy for quality assessment of human tissue samples: report of the tissue Biospecimen Research Working Group of the Spanish Biobank Network

寻求基于证据的人体组织样本质量评估策略:西班牙生物样本库网络组织生物样本研究工作组报告

Esteva-Socias, Margalida; Artiga, María-Jesús; Bahamonde, Olga; Belar, Oihana; Bermudo, Raquel; Castro, Erika; Escámez, Teresa; Fraga, Máximo; Jauregui-Mosquera, Laura; Novoa, Isabel; Peiró-Chova, Lorena; Rejón, Juan-David; Ruiz-Miró, María; Vieiro-Balo, Paula; Villar-Campo, Virginia; Zazo, Sandra; Rábano, Alberto; Villena, Cristina

Colon cancer modulation by a diabetic environment: A single institutional experience

糖尿病环境对结肠癌的调控:一项单中心研究

Prieto, Isabel; Del Puerto-Nevado, Laura; Gonzalez, Nieves; Portal-Nuñez, Sergio; Zazo, Sandra; Corton, Marta; Minguez, Pablo; Gomez-Guerrero, Carmen; Arce, Jose Miguel; Sanz, Ana Belen; Mas, Sebastian; Aguilera, Oscar; Alvarez-Llamas, Gloria; Esbrit, Pedro; Ortiz, Alberto; Ayuso, Carmen; Egido, Jesus; Rojo, Federico; Garcia-Foncillas, Jesus

Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer

MET通路激活预示着复发或转移性头颈癌患者对西妥昔单抗治疗效果不佳

Madoz-Gúrpide, Juan; Zazo, Sandra; Chamizo, Cristina; Casado, Victoria; Caramés, Cristina; Gavín, Eduardo; Cristóbal, Ion; García-Foncillas, Jesús; Rojo, Federico

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer

胸苷酸合成酶表达作为晚期非小细胞肺癌对培美曲塞敏感性的预测性生物标志物

Chamizo, Cristina; Zazo, Sandra; Dómine, Manuel; Cristóbal, Ion; García-Foncillas, Jesús; Rojo, Federico; Madoz-Gúrpide, Juan

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects

PP2A抑制导致早期乳腺癌预后不良和多柔比星耐药,而其激活则显示出良好的治疗效果。

Rincón, Raúl; Cristóbal, Ion; Zazo, Sandra; Arpí, Oriol; Menéndez, Silvia; Manso, Rebeca; Lluch, Ana; Eroles, Pilar; Rovira, Ana; Albanell, Joan; García-Foncillas, Jesús; Madoz-Gúrpide, Juan; Rojo, Federico